Bliss GVS Pharma - Quaterly Results

29 Jul 2025 Evaluate
A fair growth of 9.67% in the revenue at Rs. 1633.64 millions was reported in the June 2025 quarter as compared to Rs. 1489.63 millions during year-ago period.A humble growth in net profit of 8.41% reported in the quarter ended June 2025 to Rs. 210.54  millions from Rs. 194.21 millions.Operating profit for the quarter ended June 2025 rose to 433.61 millions as compared to 335.83 millions of corresponding quarter ended June 2024.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 1633.64 1489.63 9.67 1633.64 1489.63 9.67 6672.05 6054.60 10.20
Other Income 105.93 68.41 54.85 105.93 68.41 54.85 362.16 335.01 8.10
PBIDT 433.61 335.83 29.12 433.61 335.83 29.12 1278.02 1406.68 -9.15
Interest 51.12 11.68 337.67 51.12 11.68 337.67 65.84 58.06 13.40
PBDT 382.49 324.15 18.00 382.49 324.15 18.00 1212.18 937.76 29.26
Depreciation 76.85 62.61 22.74 76.85 62.61 22.74 270.47 235.19 15.00
PBT 305.64 261.54 16.86 305.64 261.54 16.86 941.71 702.57 34.04
TAX 95.10 67.33 41.24 95.10 67.33 41.24 252.03 196.13 28.50
Deferred Tax -30.39 -2.95 930.17 -30.39 -2.95 930.17 -47.89 -75.49 -36.56
PAT 210.54 194.21 8.41 210.54 194.21 8.41 689.68 506.44 36.18
Equity 105.50 104.88 0.59 105.50 104.88 0.59 105.37 104.69 0.65
PBIDTM(%) 26.54 22.54 17.73 26.54 22.54 17.73 19.15 23.23 -17.55

Bliss GVS Pharma Share Price

172.15 7.75 (4.71%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×